c Ex vivo assay systems provide a powerful approach to studying human malaria parasite biology and to testing antimalarials. For rodent malaria parasites, short-term in vitro culture and ex vivo antimalarial susceptibility assays are relatively cumbersome, relying on in vivo passage for synchronization, since ring-stage parasites are an essential starting material. Here, we describe a new approach based on the enrichment of ring-stage Plasmodium berghei, P. yoelii, and P. vinckei vinckei using a single-step Percoll gradient. Importantly, we demonstrate that the enriched ring-stage parasites develop synchronously regardless of the parasite strain or species used. Using a flow cytometry assay with Hoechst and ethidium or MitoTracker dye, we show that parasite development is easily and rapidly monitored. Finally, we demonstrate that this approach can be used to screen antimalarial drugs.T he spread of artemisinin-resistant malaria parasites in Southeast Asia requires the urgent development of new antimalarial therapeutics (1). Currently, the discovery of drugs with activity against Plasmodium falciparum follows a defined pathway (2, 3). Central to this pathway is quantifying the intrinsic susceptibility of a standard laboratory strain of P. falciparum (usually strain 3D7) to the candidate antimalarial drugs, specifically by defining their half-maximal (50%) inhibitory concentration (IC 50 ) in vitro. Lead antimalarial candidates with the lowest IC 50 s (generally Յ1 M) are then tested against cultures of a range of adapted isolates (often with well-defined resistance phenotypes) or against ex vivo fresh isolates (2,(4)(5)(6). Next, to demonstrate efficacy in vivo, rodent malaria parasite models, in particular, Plasmodium berghei ANKA (7) and P. chabaudi (8) in mice, are used. Unfortunately, it is rare for the IC 50 s of the candidate drugs for rodent malaria parasites to be determined, thus preventing meaningful comparisons of the effects of the candidate drugs on human parasites and rodent malaria parasites.In vitro drug screening methods have been developed for P. berghei ANKA. However, P. berghei ANKA parasite infections are generally asynchronous, and therefore, an in vivo synchronization step is required prior to in vitro culture of the parasite (9). Additionally, rodent malaria parasites have different infection profiles, i.e., different lethalities and synchronicities, which are also influenced by the mouse genetic background and immunity (2). As the in vivo result is confounded by the choice of rodent malaria species and strain, as well as the mouse genetic background, we need a simplified ex vivo assay to accurately determine the intrinsic profile of the susceptibility of murine Plasmodium spp. to antimalarials.In the study described here, we developed a single-step protocol to enrich the ring stages of rodent malaria parasites for shortterm in vitro culture that can be used for in vitro screening and measurement of parasite sensitivities to different antimalarial compounds using flow cytometry.
MATERIALS ...